Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023

SELL
$0.72 - $1.12 $348 - $542
-484 Reduced 0.12%
417,590 $337,000
Q4 2022

Feb 13, 2023

SELL
$0.83 - $8.04 $56,127 - $543,696
-67,624 Reduced 13.92%
418,074 $372,000
Q3 2022

Nov 10, 2022

SELL
$1.98 - $2.42 $10,484 - $12,813
-5,295 Reduced 1.08%
485,698 $1.15 Million
Q2 2022

Aug 10, 2022

SELL
$2.21 - $2.7 $35,366 - $43,208
-16,003 Reduced 3.16%
490,993 $1.11 Million
Q1 2022

May 12, 2022

BUY
$2.37 - $3.24 $67,597 - $92,411
28,522 Added 5.96%
506,996 $1.24 Million
Q4 2021

Feb 14, 2022

SELL
$2.92 - $3.76 $21,902 - $28,203
-7,501 Reduced 1.54%
478,474 $1.45 Million
Q3 2021

Nov 12, 2021

BUY
$3.28 - $4.07 $22,960 - $28,490
7,000 Added 1.46%
485,975 $1.82 Million
Q2 2021

Aug 12, 2021

BUY
$3.43 - $3.96 $191,054 - $220,575
55,701 Added 13.16%
478,975 $1.86 Million
Q1 2021

May 11, 2021

BUY
$2.2 - $3.94 $102,080 - $182,816
46,400 Added 12.31%
423,274 $1.64 Million
Q4 2020

Feb 08, 2021

BUY
$1.91 - $2.5 $33,616 - $44,000
17,600 Added 4.9%
376,874 $942,000
Q3 2020

Nov 12, 2020

BUY
$1.96 - $2.92 $16,464 - $24,528
8,400 Added 2.39%
359,274 $794,000
Q2 2020

Aug 13, 2020

SELL
$1.58 - $2.86 $21,330 - $38,610
-13,500 Reduced 3.7%
350,874 $705,000
Q1 2020

May 15, 2020

SELL
$1.43 - $3.23 $6,077 - $13,727
-4,250 Reduced 1.15%
364,374 $583,000
Q4 2019

Feb 13, 2020

BUY
$2.74 - $4.2 $1.01 Million - $1.55 Million
368,624 New
368,624 $1.22 Million

Others Institutions Holding THTX

# of Institutions
1
Shares Held
29.2K
Call Options Held
0
Put Options Held
0

About Theratechnologies Inc.


  • Ticker THTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 95,141,600
  • Market Cap $116M
  • Description
  • Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...
More about THTX
Track This Portfolio

Track Cibc World Market Inc. Portfolio

Follow Cibc World Market Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cibc World Market Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cibc World Market Inc. with notifications on news.